Cards Acccepted | 5% OFF Crypto | 3rd Party Testing | FREE Worldwide Shipping $400+
Menu
Cart
semaglutide 5-20 mg lyophilized vial
edgepeptides semaglutide 10 mg chromate test
lyophilized peptide vial box (white cap)

Semaglutide 5-20mg – 10 Vial Box

$210 – $370

Buy semaglutide 5, 10, or 20 mg (one 10-vial box). All orders are shipped wholesale in unbranded packaging. Worldwide 7 – 14 day shipping to the USA, UK, AUS & NZ.

Bulk discounts
QuantityBulk DiscountPrice
25%$200
3-57%$195
6-1010%$189
SKU: SEMCategory: Tag:

Description

Semaglutide is a peptide that helps manage blood sugar levels and supports weight loss by mimicking a natural hormone that regulates appetite and glucose. It is commonly used to aid weight loss and improve glycemic control in individuals with type 2 diabetes. Semaglutide is the generic peptide version of Wegovy/Ozempic.

Minimum order quantity: one box (10 vials x 5-20 mg, 50-200 mg in total).

Note: Product images show branded labels for illustration purposes only. All peptides are shipped in wholesale, unbranded packaging. You can see an actual example photo of the peptide vials and container above.

Additional information

Purity

≥99.0%

Molar Mass

4113.641 g·mol

Molecular Formula

C₁₈₇H₂₉₁N₄₅O₅₉

Sequence

H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH

Strength

5mg, 10mg, 15mg, 20mg, 30mg

  1. Christou, Georgios A., et al. "Semaglutide as a promising antiobesity drug." Obesity Reviews 20.6 (2019): 805-815.
  2. Smits, Mark M., and Daniël H. Van Raalte. "Safety of semaglutide." Frontiers in endocrinology 12 (2021): 645563.
  3. Marso, Steven P., et al. "Semaglutide and cardiovascular outcomes in patients with type 2 diabetes." New England Journal of Medicine 375.19 (2016): 1834-1844.
  4. Chao, Ariana M., et al. "Semaglutide for the treatment of obesity." Trends in cardiovascular medicine 33.3 (2023): 159-166.
  5. Wilding, John PH, et al. "Once-weekly semaglutide in adults with overweight or obesity." New England Journal of Medicine 384.11 (2021): 989-1002.
  6. Davies, Melanie, et al. "Effect of oral semaglutide compared with placebo and subcutaneous semaglutide on glycemic control in patients with type 2 diabetes: a randomized clinical trial." Jama 318.15 (2017): 1460-1470.
  7. Bergmann, Natasha Chidekel, et al. "Semaglutide for the treatment of overweight and obesity: a review." Diabetes, Obesity and Metabolism 25.1 (2023): 18-35.

Semaglutide 10mg Chromate Test (2025)

Semaglutide CoA (2024)

Semaglutide HPLC (2024)

Related products